• FDA grants fast track designation to NanoFlu for influenza vaccination in older adults

    8 monthes ago - By Healio

    The FDA granted fast track designation to NanoFlu for adults 65 years and older.
    “The FDA's decision to grant Fast Track Designation for NanoFlu reflects the urgent unmet medical need for a more effective vaccine against influenza, particularly in the older adult population which often experiences serious and sometimes life-threatening complications of the disease,” President and Chief Executive Officer of Novavax Stanley C. Erck said in a release.
    NanoFlu is enrolled in a 3 trial will evaluate the immunogenicity and safety of NanoFlu compared Fluzone. demonstrate noninferior
    Read more ...